JP5730192B2 - 濃度アッセイ - Google Patents

濃度アッセイ Download PDF

Info

Publication number
JP5730192B2
JP5730192B2 JP2011511570A JP2011511570A JP5730192B2 JP 5730192 B2 JP5730192 B2 JP 5730192B2 JP 2011511570 A JP2011511570 A JP 2011511570A JP 2011511570 A JP2011511570 A JP 2011511570A JP 5730192 B2 JP5730192 B2 JP 5730192B2
Authority
JP
Japan
Prior art keywords
calibration
cycle
concentration
analysis
virtual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2011511570A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011522250A (ja
Inventor
ボルグ，ピーター
フロステル−カールソン，オーサ
ヘメレイネン，マルック
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytiva Sweden AB
Original Assignee
Amersham Bioscience AB
GE Healthcare Bio Sciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Bioscience AB, GE Healthcare Bio Sciences Corp filed Critical Amersham Bioscience AB
Publication of JP2011522250A publication Critical patent/JP2011522250A/ja
Application granted granted Critical
Publication of JP5730192B2 publication Critical patent/JP5730192B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/65—Raman scattering
    • G01N21/658—Raman scattering enhancement Raman, e.g. surface plasmons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/55—Specular reflectivity
    • G01N21/552—Attenuated total reflection
    • G01N21/553—Attenuated total reflection and using surface plasmons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2470/00—Immunochemical assays or immunoassays characterised by the reaction format or reaction type
    • G01N2470/04—Sandwich assay format
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2470/00—Immunochemical assays or immunoassays characterised by the reaction format or reaction type
    • G01N2470/10—Competitive assay format

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2011511570A 2008-06-02 2009-06-01 濃度アッセイ Active JP5730192B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE0801304-7 2008-06-02
SE0801304 2008-06-02
SE0950272-5 2009-04-24
SE0950272 2009-04-24
PCT/SE2009/050638 WO2009148396A1 (en) 2008-06-02 2009-06-01 Concentration assay

Publications (2)

Publication Number Publication Date
JP2011522250A JP2011522250A (ja) 2011-07-28
JP5730192B2 true JP5730192B2 (ja) 2015-06-03

Family

ID=41398332

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011511570A Active JP5730192B2 (ja) 2008-06-02 2009-06-01 濃度アッセイ
JP2011511569A Withdrawn JP2011522249A (ja) 2008-06-02 2009-06-01 ウイルス検出方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011511569A Withdrawn JP2011522249A (ja) 2008-06-02 2009-06-01 ウイルス検出方法

Country Status (6)

Country Link
US (3) US10823677B2 (enExample)
EP (2) EP2294226A4 (enExample)
JP (2) JP5730192B2 (enExample)
CN (2) CN102046814B (enExample)
AU (2) AU2009255777A1 (enExample)
WO (2) WO2009148396A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102046814B (zh) * 2008-06-02 2015-05-20 通用电气健康护理生物科学股份公司 浓度测定
EP2718715B1 (en) * 2011-06-13 2018-12-26 InDevR, Inc. Low density microarrays for vaccine related protein quantification, potency determination and efficacy evaluation
EP2657681A1 (en) * 2012-04-26 2013-10-30 Roche Diagnostics GmbH Improvement of the sensitivity and the dynamic range of photometric assays by generating multiple calibration curves
US20150093839A1 (en) * 2013-10-02 2015-04-02 General Electric Company Methods and systems for detection of target and applications thereof
US20160313316A1 (en) * 2013-12-10 2016-10-27 Agency For Science, Technology And Research Surface acoustic wave sensor for influenza detection
KR102301688B1 (ko) * 2014-02-28 2021-09-13 닛토덴코 가부시키가이샤 소변 검사 장치 및 정량적 소변 검사를 위한 건식 시약
WO2015187158A1 (en) 2014-06-04 2015-12-10 Indevr, Inc. Universal capture array for multiplexed subtype-specific quantification and stability determination of influenza proteins
US9816912B2 (en) * 2015-03-23 2017-11-14 Intellicyt Corporation Evaluating biological material for unassociated virus-size particles having an adenovirus hexon protein epitope
GB201511587D0 (en) * 2015-07-02 2015-08-19 Ge Healthcare Bio Sciences Ab A method and a system for determining a concentration range for a sample by means of a calibration curve
US20170212050A1 (en) * 2016-01-22 2017-07-27 Ionfield Holdings, Llc Method for calibrating and using calibration of microplates
EP3296741B1 (en) * 2016-09-14 2019-08-21 Serum Institute of India Private Limited Multiplex bead based assay for quantification of multiple types of carrier protein in a multivalent conjugate vaccine composition
CN110044997B (zh) * 2018-01-15 2023-08-04 中国医学科学院药物研究所 一种体内药物的离子强度虚拟校正和定量质谱成像分析方法
GB2578163A (en) * 2018-10-19 2020-04-22 Univ Pretoria Plant produced avian influenza antigens and their uses in diagnostic assays and devices
JP7233880B2 (ja) * 2018-10-22 2023-03-07 キヤノンメディカルシステムズ株式会社 ウイルスｒｎａ単離方法及びウイルス定量方法
CN111487405A (zh) * 2020-04-03 2020-08-04 山东泰邦生物制品有限公司 一种快速高通量定量检测病毒特异性抗体的方法
CN112255212B (zh) * 2020-10-15 2022-08-05 天津大学 检测h5n1甲型流感病毒血凝素的方法
CN112557647B (zh) * 2020-12-10 2024-07-05 宁波华仪宁创智能科技有限公司 基于免疫层析技术的检测方法及应用
CN112964870B (zh) * 2021-02-03 2024-01-26 军事科学院军事医学研究院军事兽医研究所 一种基于spr生物传感器的流感病毒快速检测方法
US20240151626A1 (en) * 2022-11-04 2024-05-09 American Ecotech L.C. Mass concentration determination of particles smaller than 2.5 microns in air
DE102022134580A1 (de) * 2022-12-22 2024-06-27 Endress+Hauser Conducta Gmbh+Co. Kg Verfahren zum Kalibrieren eines Sensors im laufenden Betrieb, Sensor mit implementiertem Verfahren zur Kalibration

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85137A (en) 1987-01-21 1992-02-16 Ares Serono Res & Dev Ltd Method of assaying for a ligand using surface plasmon resonance effect
SE462408B (sv) * 1988-11-10 1990-06-18 Pharmacia Ab Optiskt biosensorsystem utnyttjande ytplasmonresonans foer detektering av en specific biomolekyl, saett att kalibrera sensoranordningen samt saett att korrigera foer baslinjedrift i systemet
SE462454B (sv) * 1988-11-10 1990-06-25 Pharmacia Ab Maetyta foer anvaendning i biosensorer
SE8804074D0 (sv) * 1988-11-10 1988-11-10 Pharmacia Ab Sensorenhet och dess anvaendning i biosensorsystem
JPH0354467A (ja) 1989-07-24 1991-03-08 Asahi Chem Ind Co Ltd ウイルス濃度の測定方法および測定装置
GB9518429D0 (en) 1995-09-08 1995-11-08 Pharmacia Biosensor A rapid method for providing kinetic and structural data in molecular interaction analysis
JP3645023B2 (ja) * 1996-01-09 2005-05-11 富士写真フイルム株式会社 試料分析方法、検量線の作成方法及びそれを用いる分析装置
SE9604575D0 (sv) 1996-12-12 1996-12-12 Biacore Ab Method and system for analyte determination
US6111652A (en) * 1998-07-14 2000-08-29 Texas Instruments Incorporated High throughput surface plasmon resonance analysis system
NZ517903A (en) * 1999-09-24 2003-10-31 Smithkline Beecham Biolog S One dose intranasal influenza virus vaccine with split influenza viral antigens
WO2002001224A1 (en) * 2000-06-27 2002-01-03 Chugai Seiyaku Kabushiki Kaisha Method of evaluating binding activity of ligand to ligand-binding protein
US6477392B1 (en) * 2000-07-14 2002-11-05 Futrex Inc. Calibration of near infrared quantitative measurement device using optical measurement cross-products
AU2005257705A1 (en) 2004-06-24 2006-01-05 Ge Healthcare Bio-Sciences Ab Method for detecting molecular surface interactions
SE0402476D0 (sv) * 2004-10-13 2004-10-13 Biacore Ab Preparation and use of a reactive solid support surface
WO2006041392A1 (en) * 2004-10-13 2006-04-20 Biacore Ab Preparation and use of a reactive solid support surface
FR2921928B1 (fr) * 2007-10-08 2011-03-04 Sanofi Pasteur Anticorps monoclonaux specifiques de l'hemagglutinine du virus grippal
CN102046814B (zh) * 2008-06-02 2015-05-20 通用电气健康护理生物科学股份公司 浓度测定

Also Published As

Publication number Publication date
EP2294227A1 (en) 2011-03-16
EP2294227B1 (en) 2015-08-12
US20210215613A1 (en) 2021-07-15
CN102046815A (zh) 2011-05-04
CN102046814A (zh) 2011-05-04
US20110076703A1 (en) 2011-03-31
JP2011522249A (ja) 2011-07-28
EP2294226A1 (en) 2011-03-16
EP2294226A4 (en) 2011-09-28
JP2011522250A (ja) 2011-07-28
AU2009255777A1 (en) 2009-12-10
US10823677B2 (en) 2020-11-03
WO2009148395A1 (en) 2009-12-10
WO2009148396A1 (en) 2009-12-10
CN102046814B (zh) 2015-05-20
AU2009255776A1 (en) 2009-12-10
EP2294227A4 (en) 2011-10-12
US20110070574A1 (en) 2011-03-24

Similar Documents

Publication Publication Date Title
JP5730192B2 (ja) 濃度アッセイ
JP7456653B2 (ja) センサー表面でアナライト－リガンド結合を測定するための方法
US10545090B2 (en) Method and system for more reliable determination of interaction parameters for low affinity analytes
WO2006001749A1 (en) Method for detecting molecular surface interactions
WO2006135309A2 (en) Method and system for affinity analysis
CN102667447B (zh) 用于结合行为分析的方法和系统
WO2016066591A1 (en) Method to determine solvent correction curves
US20110152120A1 (en) method of characterizing antibodies
CN107076671A (zh) 光学传感器表面上的质量传输性质的归一化

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120327

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130326

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20130906

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130917

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20131217

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140722

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150310

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150407

R150 Certificate of patent or registration of utility model

Ref document number: 5730192

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250